Psychometrics and normative data for the multiple sclerosis functional composite: Replacing the PASAT with the symbol digit modalities test

Multiple Sclerosis

Volumn 16, Issue 2, 2010, Pages 228-237

  Benedict, R H B ^a   Drake, A S ^a   Weinstock Guttman, B ^a   Morrow, S A ^b   Hojnacki, D ^a   Munschauer, F E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b JACOBS NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Multiple sclerosis; Neuropsychology; Psychometrics

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISABILITY; DISEASE COURSE; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS FUNCTIONAL COMPOSITE; NEUROLOGIC DISEASE; PACED AUDITORY ADDITION TEST; PREDICTION; PSYCHOMETRY; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; SYMBOL DIGIT MODALITIES TEST; TEST RETEST RELIABILITY;

ADULT; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEPRESSION; DISABILITY EVALUATION; DISEASE PROGRESSION; FATIGUE; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 76449087199     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509354552     Document Type: Article

References (51)

1. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis funcitonal composite as a clinical trial outcome measure. Brain 1999 ; 122: 871-882.
2. Fischer JS, Rudick RA, Cutter GR, Reingold SC The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999 ; 5: 244-250.
3. Rudick RA, Cutter G., Baier M., et al. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Neurol 2001 ; 56: 1324-1330. (Pubitemid 32455292)
4. Cohen JA, Cutter GR, Fischer JS, et al. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Arch Neurol 2001 ; 58: 961-967.
5. Hobart J., Kalkers N., Barkhof F., et al. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite. Mult Scler 2004 ; 10: 41-46.
6. Kaufman M., Moyer D., Norton J. The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite. Mult Scler 2000 ; 6: 286-290.
7. Kragt JJ, van der Linden FA, Nielsen JM, Uitdehaag BM, Polman CH Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis. Mult Scler 2006 ; 12: 594-598.
8. Deloire MS, Bonnet MC, Salort E., et al. How to detect cognitive dysfunction at early stages of multiple sclerosis Mult Scler 2006 ; 12: 445-452.
9. Coo H., Hopman WM, Edgar CM, McBride EV, Brunet DG The Paced Auditory Serial Addition Test: to what extent is it performed as instructed, and is it associated with disease course? Mult Scler 2005 ; 11: 85-89.
10. Rao SM, Leo GJ, Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurol 1991 ; 41: 685-691.
11. Patti F. Cognitive impairment in multiple sclerosis. Mult Scler 2009 ; 15: 2-8.
12. Amato MP, Zipoli V., Portaccio E. Mulitple-sclerosis related cognitive changes: A review of cross-sectional and longitudinal studies. J Neurol Sci 2006 ; 245: 41-46.
13. Benedict RHB, Cookfair D., Gavett R., et al. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc 2006 ; 12: 549-558.
14. Gronwall DMA. Paced auditory serial addition task: A measure of recovery from concussion. Percep Mot Skills 1977 ; 44: 367-373.
15. Rosti E., Hamalainen P., Koivisto K., Hokkanen L. PASAT in detecting cognitive impairment in relapsing-remitting MS. Appl Neuropsychol 2007 ; 14: 101-112.
16. Nagels G., Geentjens L., Kos D., et al. Paced visual serial addition test in multiple sclerosis. Clin Neurol Neurosurg 2005 ; 107: 218-222.
17. Parmenter BA, Shucard JL, Benedict RHB, Shucard DW Working memory deficits in multiple sclerosis: Comparison between the n-back task and the Paced Auditory Serial Addition Test. J Int Neuropsychol Soc 2006 ; 12: 677-687.
18. Parmenter BA, Shucard JL, Shucard DW Information processing deficits in multiple sclerosis: A matter of complexity. J Int Neuropsychol Soc 2007 ; 13: 417-423.
19. Benedict RHB, Fischer JS, Archibald CJ, et al. Minimal neuropsychological assessment of MS Patients: A consensus approach. Clin Neuropsychol 2002 ; 16: 381-397.
20. Aupperle RL, Beatty WW, Shelton Fde N., Gontkovsky ST Three screening batteries to detect cognitive impairment in multiple sclerosis. Mult Scler 2002 ; 8: 382-389.
21. Williams J., O?Rourke K., Hutchinson M., Tubridy N. The Face-Symbol Test and the Symbol-Digit Test are not reliable surrogates for the Paced Auditory Serial Addition Test in multiple sclerosis. Mult Scler 2006 ; 12: 599-604.
22. Barker-Collo SL Within session practice effects on the PASAT in clients with multiple sclerosis. Arch Clin Neuropsychol 2005 ; 20: 145-152.
23. Bever C., Grattan L., Panitch HS, Johnson KP The brief repeatable battery of neuropsychological tests for multiple sclerosis: A preliminary serial study. Mult Scler 1995 ; 1: 165-169.
24. Smith A. Symbol digit modalities test: Manual. Los Angeles: Western Psychological Services, 1982.
25. Rao SM Neuropsychological Screening Battery for Multiple Sclerosis, 1991.
26. Rao SM A Manual for the Brief, Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis, 1991.
27. Benedict RHB. Effects of using same vs. alternate form memory tests in short-interval, repeated assessment in multiple sclerosis. J Int Neuropsychol 2005 ; 11: 727-736.
28. Benedict RHB, Weinstock-Guttman B., Fishman I., et al. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004 ; 61: 226-230.
29. Benedict RHB, Bruce JM, Dwyer MG, et al. Neocortical atrophy, third ventricular width, and cognitive dysfunciton in multiple sclerosis. Arch Neurol 2006 ; 63: 1301-1306.
30. Christodoulou C., Krupp LB, Liang Z., et al. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 2003 ; 60: 1793-1798.
31. Parmenter BA, Weinstock-Guttman B., Garg N., Munschauer F., Benedict RHB Screening for cognitive impairment in MS using the Symbol Digit Modalities Test. Mult Scler 2007 ; 13: 52-57.
32. Benedict RHB, Wahlig E., Bakshi R., et al. Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005 ; 29-34.
33. Brochet B., Deloire MS, Bonnet M., et al. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study. Mult Scler 2008 ; 14: 1242-1249.
34. Polman CH, Reingold SC, Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ?McDonald Criteria?. Ann Neurol 2005 ; 58: 840-846.
35. Miller D., Barkhof F., Montalban X., Thompson A., Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005 ; 4: 281-288. (Pubitemid 40545039)
36. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Ann Neurol 1983 ; 13: 227-231.
37. Parmenter BA, Zivadinov R., Kerenyi L., et al. Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) sorting tests in multiple sclerosis. J Clin Exp Neuropsychol 2007 ; 29: 215-223.
38. Mathiowetz V., Weber K., Kashman N., Volland G. Adult norms for the Nine Hole Peg Test of finger dexterity. Occupational Therapy Journal of Research 1985 ; 5: 24-38.
39. Beck AT, Steer RA, Brown GK BDI-Fast Screen for Medical Patients: Manual. San Antonio, TX: Psychological Corporation, 2000.
40. Benedict RHB, Fishman I., McClellan MM, Bakshi R., Weinstock-Guttman B. Validity of the Beck Depression Inventory - Fast Screen in multiple sclerosis. Mult Scler 2003 ; 9: 393-396.
41. Krupp LB, LaRocca NG, Muir-Nash J., Steinberg AD The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989 ; 46: 1121-1123.
42. Tombaugh TN A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). Arch Clin Neuropsychol 2006 ; 21: 53-76.
43. Benedict RHB, Duquin JA, Jurgensen S., et al. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler 2008 ; 940-946.
44. Fox RJ, Lee JC, Rudick RA Optimal reference population for the multiple sclerosis functional composite. Mult Scler 2007 ; 13: 909-914.
45. Huijbregts SC, Kalkers NF, de Sonneville LM, de Groot V., Reuling IE, Polman CH Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurol 2004 ; 63: 335-339.
46. Nocentini U., Pasqualetti P., Bonavita S., et al. Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler 2006 ; 12: 77-87.
47. Parmenter BA, Weinstock-Guttman B., Garg N., Munschauer F., Benedict RHB Screening for cognitive impairment in MS using the Symbol Digit Modalities Test. Mult Scler 2006 ; in press.
48. Bermel RA, Bakshi R., Tjoa C., Puli SR, Jacobs L. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 2002 ; 59: 275-280.
49. Amato MP, Bartolozzi ML, Zipoli V., et al. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurol 2004 ; 63: 89-93.
50. Tekok-Kilic A., Benedict RHB, Weinstock-Guttman B., et al. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. NeuroImage 2007 ; 36: 1294-1300.
51. Houtchens MK, Benedict RHB, Killiany R., et al. Thalamic atrophy and cognition in multiple sclerosis. Neurol 2007 ; 69: 113-123.